H-IYPTNGYTR-OH

Ref. 3D-PP41982

Informations sur le produit

• Nom: H-IYPTNGYTR-OH

Description

Peptide H-IYPTNGYTR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IYPTNGYTR-OH include the following: Improving trastuzumab's stability profile by removing the two degradation hotspots Y Yang, J Zhao, S Geng, C Hou, X Li, X Lang - Journal of , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354915300861 Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab S Schokker , F Fusetti, F Bonardi, RJ Molenaar - MAbs, 2020 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/19420862.2020.1795492 Fast analysis of antibody-derived therapeutics by automated multidimensional liquid chromatography-mass spectrometry S Pot, C Gstöttner , K Heinrich, S Hoelterhoff - Analytica Chimica , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003267021008412 LC-MS/MS validation analysis of trastuzumab using dSIL approach for evaluating pharmacokinetics RH Budhraja , MA Shah, M Suthar, A Yadav , SP Shah - Molecules, 2016 - mdpi.comhttps://www.mdpi.com/1420-3049/21/11/1464 Improved sensitivity for LC-MS quantitation of biologics in plasma using Trap-and-Elute MicroLC-MS R van Soest, K Motamedchaboki , S Heidelberger - sciex.jphttps://sciex.jp/content/dam/SCIEX/pdf/posters/asms2017/clinical/657_van%20Soest.pdf LC-MS/MS-Based Monitoring of In Vivo Protein Biotransformation: Quantitative Determination of Trastuzumab and Its Deamidation Products in Human Plasma P Bults , R Bischoff , H Bakker, JA Gietema - Analytical , 2016 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.5b04276 Analytical and pharmacological consequences of the in vivo deamidation of trastuzumab and pertuzumab P Bults , A van der Voort, C Meijer, GS Sonke - Analytical and , 2022 - Springerhttps://link.springer.com/article/10.1007/s00216-021-03756-z and Takashi Shimada N Iwamoto, N Yamane, Y Umino, A Hamadac - researchgate.nethttps://www.researchgate.net/profile/Akinobu-Hamada/publication/283003878_Development_of_the_validated_LCMS_bioanalysis_of_Trastuzumab_in_human_plasma_using_selective_detection_method_for_complementarity-determining_regions_of_monoclonal_antibody_nano-surface_and_molecular-/links/56582f5008aefe619b207dac/Development-of-the-validated-LCMS-bioanalysis-of-Trastuzumab-in-human-plasma-using-selective-detection-method-for-complementarity-determining-regions-of-monoclonal-antibody-nano-surface-and-molecular.pdf The development of the validated LCMS bioanalysis of trastuzumab in human plasma using a selective detection method for complementarity-determining regions of N Iwamoto, N Yamane, Y Umino, A Hamada - Analytical , 2015 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2015/ay/c5ay01588j LC-MS bioanalysis of Trastuzumab and released emtansine using nano-surface and molecular-orientation limited (nSMOL) proteolysis and liquid-liquid N Iwamoto, A Shimomura, K Tamura, A Hamada - of Pharmaceutical and , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0731708517311822 Hybrid Ligand Binding Immunoaffinity-Liquid Chroma-tography/Mass Spectrometry for Biotherapeutics and M Yuan, OA Ismaiel , WRM Jr - 2019 - pdfs.semanticscholar.orghttps://pdfs.semanticscholar.org/a57d/c39364ae847316dcdbc73959ae03331577fb.pdf Hybrid ligand binding immunoaffinity-liquid chromatography/mass spectrometry for biotherapeutics and biomarker quantitation: how to develop a hybrid LBA M Yuan, OA Ismaiel , WRJ Mylott - Rev , 2019 - betasciencepress-publishing.comhttps://betasciencepress-publishing.com/10-17145/fulltext/rss/hybrid-ligand-binding-immunoaffinity-liquid-chromatography-mass-spectrometry-for-biotherapeutics-and-biomarker-quantitation-how-to-develop-a-hybrid-lba-lc-ms-ms-method-for-a-protein/ Use of an alternative signature peptide during development of a LC-MS/MS assay of plasma nivolumab levels applicable for multiple species M Ohuchi, S Yagishita , K Taguchi, Y Goto - of Chromatography B, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1570023220313659 Antibody Drug Conjugate Bioanalysis using the BioBA Solution M Deng, I Moore - sciex.jphttps://sciex.jp/content/dam/SCIEX/pdf/tech-notes/all/ADC-Bioanalysis-BioBA-solution.pdf Advantages of extended bottom-up proteomics using Sap9 for analysis of monoclonal antibodies K Srzentić , L Fornelli , UA Laskay, M Monod - Analytical , 2014 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ac502766n Investigation of native and aggregated therapeutic proteins in human plasma with asymmetrical flow field-flow fractionation and mass spectrometry I Ramm , M Leeman , H Schagerlöf, IR Leon - Analytical and , 2022 - Springerhttps://link.springer.com/article/10.1007/s00216-022-04355-2 Development of an efficient mAb quantification assay by LC-MS/MS using rapid on-bead digestion HH Chiu , YJ Tsai, C Lo, CH Lin, IL Tsai, CH Kuo - Analytica Chimica Acta, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003267021011454 Quantification of the Antibody Drug Conjugate, Trastuzumab Emtansine, and the Monocolonal Antibody, Trastuzumab, in Plasma Using a Generic Kit-Based H Yang, ME Lame, S Naughton, EE Chambers - waters.comhttps://www.waters.com/content/dam/waters/en/app-notes/2016/720005619/720005619-en.pdf Improving Quantification of Protein Therapeutics by Standardising the Sample Preparation Approach to LC-MS/MS Analysis: High-sensitivity Bioanalysis of EE Chambers, ME Lame - 2016 - researchgate.nethttps://www.researchgate.net/profile/Karen-Haas/publication/303483394_Improving_Quantification_of_Protein_Therapeutics_by_Standardising_the_Sample_Preparation_Approach_to_LC-MSMS_Analysis_High-sensitivity_Bioanalysis_of_Infliximab_and_Total_Antibody_Quantification_of_th/links/5744963c08ae9ace8421a432/Improving-Quantification-of-Protein-Therapeutics-by-Standardising-the-Sample-Preparation-Approach-to-LC-MS-MS-Analysis-High-sensitivity-Bioanalysis-of-Infliximab-and-Total-Antibody-Quantification-of.pdf Comparative study of trastuzumab modification analysis using mono/multi-epitope affinity technology with LC-QTOF-MS C Zuo, J Zhou, S Bian , Q Zhang, Y Lei, Y Shen - Journal of , 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2095177924001126 Separation of deamidated peptides with mixed-mode chromatography using phospholipid-functionalized monolithic stationary phases C Liu, P Bults , R Bischoff , J Crommen , Q Wang - of Chromatography A, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021967319305771 Aptamer-based sample purification for mass spectrometric quantification of trastuzumab in human serum B Sun, J Liu, P Cai, J Wu, W Liu, H Hu, L Liu - Talanta, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0039914023001005 Analytical tools for the characterization of deamidation in monoclonal antibodies B Spanov, N Govorukhina, NC van de Merbel - Journal of , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2772391721000256

• Marque: Biosynth